Surmodics | 销售成本

金融业

USD

USD 178.56M

现金及等价物

USD 36.12M

USD 33.03M

USD 81.3M

USD 20.54M

USD 29.55M

股息收益率

0

USD -322K

USD 1.53M

376

EPS每股收益

USD -0.25

股本和储备

USD 118.9M

USD -11.54M

债务利息支出

USD 884K

USD 29.55M

USD 393.5M

USD -11.54M

USD -245.35M

USD -5.65M

普通股股本

USD 716K

386.18

USD -7.51M

USD 29.92M

销售和管理费用

USD 14.58M

USD 15.17M

贸易债权人

USD 2.79M

应收帐款人

USD 23.27M

	销售成本	更改		日
Abbott	USD 4.92B		535M	2025-12
Align Technology	USD 363.97M		7.48M	2025-12
Anika Therapeutics	USD 11.49M		35.48M	2025-03
Baxter International	USD 1.88B		66M	2025-09
Boston Scientific	USD 1.84B		82M	2025-12
EDAP TMS	EUR 9.22M		1.36M	2025-06
Edwards Lifesciences	USD 343M		2.2M	2025-12
Haemonetics	USD 136.58M		4.01M	2025-12
Heron Therapeutics	USD 9.46M		1.61M	2024-09
J&J	USD 7.97B		689M	2025-12
Merit Medical Systems	USD 197.75M		229K	2025-09
Mesa Laboratories	USD 21.92M		1.78M	2024-09
Nektar Therapeutics	USD 4.43M		5.3M	2024-09
Option Care Health	USD 1.18B		31.36M	2025-09
Stryker	USD 2.69B		373M	2025-12
Surmodics	USD 33.03M		24.58M	2024-09
Trinity Biotech	USD 7.84M		3.14M	2025-09

Surmodics 销售成本 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.